battle of glp-1 delivery technologies Disruptive Innovations Shaping the Landscape GLP-1 Medications Are Revolutionizing Healthcare

Type 1 diabetes is unique amongst many of the chronic diseases where escalation of therapy does not routinely include the addition of alternative adjunctive pharmacotherapy

Fortunately, some of this can be mitigated by eating enough protein and doing regular strength training

Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA

When it comes to reduction of weight-related issues like diabetes, heart disease risks and metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), bariatric surgery far outpaces GLP-1s in reduction, and often removal, of these risks

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study